UNIGENE LABORATORIES, INC.,is a biopharmaceutical company. The Company focuses on the research, production and delivery of small proteins, referred to as peptides, for medical use. The Company has three operating locations: administrative and regulatory offices in Boonton, New Jersey; a laboratory researches facility in Fairfield, New Jersey, and a pharmaceutical production facility in Boonton, New Jersey. Initially the Company's was focused on the development of calcitonin and other peptide products for the treatment of osteoporosis and other indications. The Company's first product to market is Fortical, a nasal calcitonin product, received approval from the United States Food and Drug Administration in 2005. It is marketed in the United States by Upsher-Smith Laboratories, Inc., for the treatment of postmenopausal osteoporosis. The Company's product other than Fortical, will require clinical trials and approvals from regulatory agencies.
UNIGENE LABORATORIES INC 
